From: The Proliferation REduction with Vascular ENergy Trial (PREVENT)
 | 32P group (n = 80) | Control (n = 25) | P value |
---|---|---|---|
Acute gain (mm) | 1.9 ± 0.6 (n = 80) | 1.9 ± 0.4 (n = 25) | ns |
Late lumen loss (mm) | 0.2 ± 0.6 (n = 73) | 1.1 ± 0.7 (n = 23) | <0.0001 |
Late loss index (%) | 11 ± 36 (n = 73) | 55 ± 30 (n = 23) | <0.0001 |
Binary restenosis (>50%) | Â | Â | Â |
   Target site | 6/73 (8%) | 9/23 (39%) | 0.0012 |
   Target site plus adjacent segments | 17/76 (22%) | 12/24 (50%) | 0.018 |